OLOMOUC, Czech Republic, January 23, 2018 /PRNewswire/ --
Scientists from the Palacký University (UP) in Olomouc have discovered a unique mechanism that enables bacteria to defend themselves against silver nanoparticles, which are widely used in antibacterial therapy. This mechanism does not require the bacteria to undergo genetic changes, and differs significantly from mechanisms of antibiotic resistance. The scientists have also found a way to suppress bacterial resistance to nanosilver, which could be crucial in addressing the global antibiotics crisis. The revolutionary discovery was published in January on the cover page of the journalNature Nanotechnology, arguably the world's most prestigious journal in the nanotechnology field. This is also the first paper published in this journal that was written exclusively by Czech authors.
"It is well known that silver nanoparticles lose their antimicrobial activity if they come together to form larger particles known as aggregates. We have discovered that flagellar bacteria can exploit this Achilles' heel: upon repeated exposure to nanosilver, they start producing the protein flagellin from their flagella. This protein first reduces the repulsive forces between the nanoparticles and then acts like glue, causing the nanoparticles to stick to one-another and lose their antibacterial properties," said Aleš Paná?ek from RCPTM, the first author of the work, identifying it as a unique resistance mechanism.
Unlike antibiotic resistance, however, scientists have discovered a way to counter this problem. "Resistance can be easily overcome by adding substances that suppress the formation and release of flagellin. Suitable substances are found in pomegranate extracts, among other things. If such extracts are applied together with silver nanoparticles, the bacteria do not produce flagellin and therefore lose their resistance to silver nanoparticles," explained Libor Kvítek from RCPTM, who has pioneered nanosilver research at Olomouc.
The Czech scientists see the mechanism's discovery as a piece of good news at a time of widespread concern about a global antibiotics crisis. "Every year, hundreds of thousands of people die because antibiotics are losing their effectiveness against bacteria that have developed antibiotic resistance as a result of genetic changes. The surprising resistance mechanism that bacteria develop upon repeated exposure to silver nanoparticles simply proves that the oldest and most widespread organisms on our planet are continually acquiring new weapons in their ongoing struggle with scientists. However, it is important that this mechanism does not have a genetic basis and we can find ways to counter these weapons," said Milan Kolá?, the head of the Department of Microbiology at the Medical Faculty of the Palacký University in Olomouc and a leading specialist in the study and treatment of bacterial infections.
According to the scientists, silver nanoparticles have a lot more to contribute in the fight against bacterial infections. The team from Olomouc has developed a technology protected by European and American patents that involves using strong chemical bonds to anchor silver nanoparticles to materials such as plastics, metals, and textiles. "This kind of antimicrobial surface treatment prevents the formation of bacterial films, and several companies in Europe have shown interest in its use. We think this is the way forward because the tight binding of silver nanoparticles prevents their aggregation, and hence the occurrence of flagellin-based bacterial resistance, while simultaneously preventing the nanoparticles from being released into the body or the environment," said Radek Zbo?il, the director of RCPTM and a corresponding author of the work published in Nature Nanotechnology.
The scientists from Olomouc have reported several other important results in recent years, describing, among other things, the high activity of silver nanoparticles against yeasts and the possibility of restoring antibiotics' activity against multi-resistant bacteria while simultaneously applying nanosilver at very low concentrations that are non-toxic to mammalian cells.
Contact: Radek Zbo?il / General Director Regional Centre of Advanced Technologies and Materials Šlechtitel? 27 78371 Olomouc, Czech Republic Phone: (+420)-775-733-378 Email: email@example.com
References: A. Paná?ek, L. Kvítek, M. Smékalová, R. Ve?e?ová, M. Kolá?, M. Röderová, F. Dy?ka, M. Šebela, R. Prucek, O. Tomanec, and R. Zbo?il: Bacterial resistance to silver nanoparticles and how to overcome it, NATURE NANOTECHNOLOGY, vol. 13, iss. 1, pp. 65-71, 2018. A. Paná?ek, M. Kolá?, R. Ve?e?ová, R. Prucek, J. Soukupová, V. Kryštof, P. Hamal, R. Zbo?il, and L. Kvítek: Antifungal activity of silver nanoparticles against Candida spp., BIOMATERIALS, vol. 30, iss. 31, pp. 6333-6340, 2009. A. Paná?ek, L. Kvítek, R. Prucek, M. Kolá?, R. Ve?e?ová, N. Pizúrová, V. K. Sharma, T. Nev??ná, and R. Zbo?il: Silver colloid nanoparticles: Synthesis, characterization, and their antibacterial activity, JOURNAL OF PHYSICAL CHEMISTRY B, vol. 110, iss. 33, pp. 16248-16253, 2006. A. Paná?ek, M. Smékalová, R. Ve?e?ová, K. Bogdanová, M. Röderová, M. Kolá?, M. Kilianová, Š. Hradilová, J. P. Froning, M. Havrdová, R. Prucek, R. Zbo?il, and L. Kvítek: Silver nanoparticles strongly enhance and restore bactericidal activity of inactive antibiotics against multiresistant Enterobacteriaceae, COLLOIDS AND SURFACES B: BIOINTERFACES, vol. 142, pp. 392-399, 2016. R. Zbo?il, J. Soukupová, Method of immobilization of silver nanoparticles on solid substrates, patents: US 9505027, EP2701515. A. Paná?ek, L. Kvítek, R. Prucek, M. Kolá? and R. Zbo?il, Antibiotic preparation and use thereof, patent: EP2950804.
SOURCE Palacký University
Subscribe to our Free Newsletters!
Fennel seeds are a must-have in almost every Indian kitchen due to its health quotient. Here are a ...
True vertigo is a severe form of dizziness that is a movement hallucination. Try out some of these ...
Oxidative stress is a form of injury to body tissues due to increase in free radicals. If the ...View All